CID 113041

63134-02-1

Structural Information

Molecular Formula
C21H25N5OS
SMILES
CCN(CCNC(=O)C)C1=CC(=C(C=C1)N=NC2=NC3=C(S2)C=C(C=C3)C)C
InChI
InChI=1S/C21H25N5OS/c1-5-26(11-10-22-16(4)27)17-7-9-18(15(3)13-17)24-25-21-23-19-8-6-14(2)12-20(19)28-21/h6-9,12-13H,5,10-11H2,1-4H3,(H,22,27)
InChIKey
VAAUVVLIZRXVHB-UHFFFAOYSA-N
Compound name
N-[2-[N-ethyl-3-methyl-4-[(6-methyl-1,3-benzothiazol-2-yl)diazenyl]anilino]ethyl]acetamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

395.17798 Da
Monoisotopic Mass

5.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 396.185256 196.3
[M+Na]+ 418.167198 203.6
[M-H]- 394.170704 207.0
[M+NH4]+ 413.211803 210.7
[M+K]+ 434.141138 199.5
[M+H-H2O]+ 378.175240 186.2
[M+HCOO]- 440.176181 220.6
[M+CH3COO]- 454.191831 239.0
[M+Na-2H]- 416.152646 198.5
[M]+ 395.17743142 204.5
[M]- 395.17852858 204.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.